ICON plc | Clinical Research Organisation (CRO) for Drug Development

Webinar: Effective Ingestion and Normalization of RWD Sources

Using Technology Advancements to Produce Powerful Real World Evidence (RWE)

Webinar: A Novel Approach to ALS Trial Development

Review insights on ALS studies and recruitment challenges involving newly diagnosed rare disease participants.

Personalising Digital Health Solutions

Develop digital health solutions to improve clinical R&D efficiency and patient outcomes

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

16 April 2019

ePharma IMPACT 2019 Recap

ICON's Travis Tingey attended the recent ePharma IMPACT conference and shares his thoughts on notable trends and themes.

15 April 2019

Reflections from MAPS Conference 2019

ICON Medical Communications attended the 2019 MAPS Annual Meeting and share key themes and trends.

15 April 2019

AMCP Annual Meeting 2019 Recap

Key topics and trends covered at the AMCP 2019 Annual Meeting.

11 April 2019

Accelerating Drug Development for Patients with Rare Diseases

CROs can help to create more patient-centric trials placing the patients’ needs and day to day life as the highest priority in protocol and operational design.

18 March 2019

Benefits of Implementing a Unified Patient Experience in Clinical Trials

Inconsistent patient engagement has been a leading challenge in clinical trials. Learn how to overcome this challenge and maximise your trial's potential today.

14 March 2019

A New Reality: EMA Published First Guidance on New MDR/IVDR Rules for Certain Devices

EMA recently published the first of a series of guidance documents to help applicants prepare for obligations enforced by new EU regulations on medical devices.

05 February 2019

ADDPLAN® neo Blog Series

Read about our latest version of the ADDPLAN® Platform, ADDPLAN® neo, a fully validated, stand-alone, fixed and adaptive design simulation and analysis tool.

05 February 2019

Regulatory Agencies Encourage Use of Adaptive Designs

Over the past few years, regulators (FDA, EMA & PMDA) have provided guidance on the use of adaptive design for clinical development. Learn more here.

05 February 2019

An Introduction to Applications of Adaptive Design: Avoiding Unnecessary Delays, Failures

Learn how the adoption of an adaptive design strategy across the product development process brings a number of important benefits in this blog.

Services

Therapeutics

Innovation

Insights

News & Events

About ICON

MDR/IVDR brings higher costs and bottlenecks

Drug Safety Reporting

2019 CRO Leadership Awards

Key Considerations in Chronic Pain Clinical Trials